Went public 10/26/00 at $7 per share
Filing Range:6.4 million shares @ $7 to $9
Shares Outstanding:25.4 million shares
Underwriters: UBS Warburg/Chase H&Q/ William Blair & Co. Company Counsel: Winston & Strawn
Manager Counsel: Dewey Ballantine LLP
Auditor: KPMG LLP
Provides research & development outsourcing to pharmaceutical firms and companies that use chemical research to develop new products. Clients also include agriculture companies and personal care companies. The company is divided into custom synthesis, combinatorial chemistry, cGMP synthesis and analytical services.
Credit Suisse First Boston
Chase Capital Partners
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 06/28/1999 4 Early Stage 35000.0
(Data in $ millions)
Total Revenues: $15.3
Net Income: 1.1